The pps bull signal may yet prove to be a Cheshire Cat, disappearing without a trace. That doesn't detract from my bullish assessment posted last Friday.
trend | adx | psar | pps | macd | macd trend | sto | sto zone | |
---|---|---|---|---|---|---|---|---|
LVS $29.06 |
Friday's post gives the detailed argument to love this stock as a bull play: Upswing since early 2009, above the 20-day and 200-day moving averages, fast stochastic bull phase, macd trending toward the zero line and bulldom.
Today's intra-day rise, up 3% low to high, pushed the price through the midline on the weekly-pivot Person's chart.
Person's Table
pps | pps open | upper pivot | lower pivot | |
---|---|---|---|---|
LVS $29.06 | $28.70 sep1 | $30.58 +5.2% | $27.52 -5.3% |
Reversal Levels
- $30.47, +4.9% (swing high)
- $28.06 <== You are here.
- $28.74, -1.1% (20-day ma)
- $27.02, -7.0% (swing low)
- $21.42, -26.3% (200-day ma)
Tim Bovee, Private Trader tracks the trades of a private trader for his own accounts. Nothing in this blog constitutes a recommendation to buy or sell stocks, options or any other financial instrument. The only purpose of this blog is to provide education and entertainment. No trader is ever 100 percent successful in his or her trades. Trading in the stock and option markets is risky and uncertain. Each trader must make trading decision decisions for his or her own account, and take responsibility for the consequences.Abbreviations:
- psar - Parabolic Stop and Reverse
- adx - Average Directional Index
- pps - Person's Proprietary Signal
- ma20 - 20-day moving average
- macd - Moving Average Convergence-Divergence
- sto - Fast Stochastic
- trend: Determined by the 5-day moving average, green for up, red for down, yellow for sideways
- adx: orange for above 30-up, blue for 20-down, purple for in the middle. Red is most prone to whipsaws
- psar, pps, macd: green for bull mode, red for bear
- sto: green for overbought, red for oversold, yellow for the neutral zone.
- sto zone: green for bull phase, red for bear phase.
No comments:
Post a Comment